Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Audinate Group (AD8.AX)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (A$) Price Target (A$) Rating
2021-07-088.6210.40Buy
2021-07-099.2011.30Buy
2021-08-2310.5511.75Buy
2021-10-188.9510.75Buy
2022-02-147.4410.30Buy
2022-04-285.999.85Buy
2022-08-228.8010.20Buy
2023-02-137.8910.35Buy
2023-08-2212.4613.55Buy
2023-12-1114.39-No Rating
2024-02-1219.3321.05Buy
2024-03-2122.50-No Rating
2024-03-2620.9021.05Buy
2024-04-0919.7922.80Buy
2024-08-078.2810.90Buy
2024-08-2010.5512.20Neutral

Disclosures

  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.